Estados Unidos - inglês - NLM (National Library of Medicine)

parsolex gmp center, inc. - cycloserine (unii: 95ik5ki84z) (cycloserine - unii:95ik5ki84z) - cycloserine 250 mg in 250 mg - seromycin is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. like all antituberculosis drugs, seromycin should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. seromycin may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram–positive and gram–negative bacteria, especially enterobacter  spp. and escherichia coli . it is generally no more and is usually less effective than other antimicrobial agents in the treatment of urinary tract infections caused by bacteria other than mycobacteria. use of seromycin in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be susceptib

Estados Unidos - inglês - NLM (National Library of Medicine)

parsolex gmp center, inc. - cycloserine (unii: 95ik5ki84z) (cycloserine - unii:95ik5ki84z) - indications and usage seromycin ® is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. like all antituberculosis drugs, seromycin ® should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. seromycin ® may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram- positive and gram-negative bacteria. use of seromycin ® in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be susceptible to the drug. contraindications administration is contraindicated in patients with any of the following: • hypersensitivity to seromycin

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - penethamate hydriodide benethamine penicillin framycetin sulfate - intramammary suspension - bovine - antibacterial

Nigéria - inglês - NAFDAC (National Agency for Food and Drugs Administration and Control)

streptomycin 5g

Nigéria - inglês - NAFDAC (National Agency for Food and Drugs Administration and Control)

streptomycin 5g

Nigéria - inglês - NAFDAC (National Agency for Food and Drugs Administration and Control)

gentamicin 80mg/2ml

Canadá - inglês - Health Canada

eli lilly canada inc - cycloserine - capsule - 250mg - cycloserine 250mg - antituberculosis agents

Filipinas - inglês - FDA (Food And Drug Administration)

n/a; importer: aglobal care, inc.; distributor: vispomed corporation - azithromycin (as dihydrate) - powder for oral suspension - 200 mg/5 ml

Egito - inglês - EDA (Egyptian Drug Authority)

pharma swede- egypt a.r.e. - spectinomycin sulphate 500mg (eq to 399,1mg spectinomycin base)+ dihydrostreptomycin sulfate 500mg (eq. to dihydrosteptomycin 399,4mg) /1gm - powder for injection

Nigéria - inglês - NAFDAC (National Agency for Food and Drugs Administration and Control)

stretomycin sulphate 5g